Mitotic inhibitor
Mitotic Inhibitor
Mitotic inhibitors are a type of chemotherapy drugs that inhibit mitosis or inhibit enzymes that are necessary for cell reproduction. They are used in cancer treatment to disrupt the cell cycle and prevent the rapid growth and division of cancer cells.
Pronunciation
mi·tot·ic in·hib·i·tor
Etymology
The term "Mitotic inhibitor" is derived from the word "Mitosis", which is a process of cell division that results in two daughter cells each having the same number and kind of chromosomes as the parent nucleus, and "Inhibitor", which refers to a substance that slows down or prevents a particular chemical reaction or other process.
Related Terms
Mechanism of Action
Mitotic inhibitors work by disrupting the process of mitosis in the M phase of the cell cycle. They bind to specific proteins and enzymes that are necessary for cell division, preventing them from functioning properly. This stops the cell from dividing and leads to cell death.
Examples of Mitotic Inhibitors
Some examples of mitotic inhibitors include paclitaxel, vinblastine, and vincristine. These drugs are often used in combination with other types of chemotherapy drugs to treat various types of cancer.
Side Effects
Like all chemotherapy drugs, mitotic inhibitors can have side effects. These can include nausea, vomiting, hair loss, and low blood cell counts. The specific side effects can vary depending on the specific drug and the individual patient.
See Also
External links
- Medical encyclopedia article on Mitotic inhibitor
- Wikipedia's article - Mitotic inhibitor
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski